Mark S. Livingston - 01 Feb 2024 Form 4 Insider Report for Progyny, Inc. (PGNY)

Signature
/s/ Mark S. Livingston
Issuer symbol
PGNY
Transactions as of
01 Feb 2024
Net transactions value
-$862,302
Form type
4
Filing time
05 Feb 2024, 19:03:00 UTC
Previous filing
05 Jan 2024
Next filing
28 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $86,900 +22,000 +47% $3.95 68,871 01 Feb 2024 Direct
transaction PGNY Common Stock Tax liability $470,435 -12,349 -18% $38.10 56,522 01 Feb 2024 Direct F1
transaction PGNY Common Stock Sale $365,097 -9,651 -17% $37.83 46,871 01 Feb 2024 Direct F1
transaction PGNY Common Stock Sale $113,670 -3,000 -6.4% $37.89 43,871 01 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -22,000 -34% $0.000000 42,627 01 Feb 2024 Common Stock 22,000 $3.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 7, 2023.
F2 These options are fully vested and exercisable.